HealthBayer Seeks FDA Approval For Regorafenib As Liver Cancer Treatment German drugmaker Bayer on Monday submitted an sNDA proposal to the FDA for the extension of its drug Regorafenib as a second-line treatment for liver cancer. The drug is currently used to treat colorectal cancer.by Alyssa Navarro
Healthy Living/WellnessFlexion Osteoarthritis Knee Pain Drug Found Effective In Late-Stage Studyby Katrina Pascual
Healthy Living/WellnessFDA Strengthens Rules For Using Mesh Implants In Pelvic Surgeriesby Katrina Pascual
Healthy Living/WellnessFDA Approval Could Make Free Autoimmune Disorder Drug Priceyby Katherine Derla
Healthy Living/WellnessFDA Approves Eli Lilly's Drug Basaglar For Diabetes Treatmentby Katrina Pascual
Healthy Living/WellnessGenetically Engineered Salmon Become First Modified Food Animal Approved For Human Consumptionby Jim Algar
Leader of Furry Hackers Raided by Feds Months After Attack on Creators of Project 2025, Former Member Claims